Disclosure 0001882764-26-000009-2

SEC FORM 4

$231,545.56

Enliven Therapeutics, Inc. (ELVN)

Sale of 6,018 shares at $38.4755 per share.

Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Oct 19, 2026 · Disclosed Oct 21, 2026

Source: SEC Form 4 · 0001882764-26-000009 · filed 2026-10-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Enliven Therapeutics, Inc. (ELVN)." Disclosed 2026-10-21. https://desqlong.com/cards/0001882764-26-000009-2 (retrieved 2026-10-22).